KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $53.4 million.

  • Emergent BioSolutions' Shares Outstanding (Weighted Average) rose 0.84% to $53.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.4 million, marking a year-over-year increase of 0.84%. This contributed to the annual value of $54.2 million for FY2024, which is 4.43% up from last year.
  • Emergent BioSolutions' Shares Outstanding (Weighted Average) amounted to $53.4 million in Q3 2025, which was down 1.71% from $54.3 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Shares Outstanding (Weighted Average) high stood at $54.3 million for Q1 2025, and its period low was $49.9 million during Q3 2022.
  • For the 3-year period, Emergent BioSolutions' Shares Outstanding (Weighted Average) averaged around $52.5 million, with its median value being $52.4 million (2024).
  • As far as peak fluctuations go, Emergent BioSolutions' Shares Outstanding (Weighted Average) declined by 7.27% in 2022, and later rose by 4.43% in 2024.
  • Emergent BioSolutions' Shares Outstanding (Weighted Average) (Quarterly) stood at $53.8 million in 2021, then decreased by 7.27% to $49.9 million in 2022, then climbed by 4.00% to $51.9 million in 2023, then grew by 4.43% to $54.2 million in 2024, then rose by 0.84% to $53.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $53.4 million in Q3 2025, compared to $54.3 million in Q2 2025 and $54.3 million in Q1 2025.